Article
Regional response leading to tumorigenesis after sulindac in small and large intestine of mice with Apc mutations.
Carcinogenesis - 1 Mar 2003
Yang Kan, Fan Kunhua, Kurihara Naoto, Shinozaki Hiroharu, Rigas Basil, Augenlicht Leonard, Kopelovich Levy, Edelmann Winfried, Kucherlapati Raju, Lipkin Martin
Abstract excerpt
Sulindac and other NSAIDs have been widely studied as potential chemopreventive agents for colon cancer. Short-term studies have shown adenomatous polyps to regress in patients with familial adenomatous polyposis (FAP). In this study the effect of sulindac on cancer as an endpoint was evaluated in ApcMin mice, a preclinical model of FAP with an Apc mutation in codon 850 that leads to gastrointestinal adenomas and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
